Is Thymosin Alpha-1 Legal? FDA, Compounding and WADA Status
Thymosin Alpha-1's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.
- FDA status
- Not approved
- approved abroad
- PCAC vote
- Not reviewed
- not on the Jul 2026 PCAC agenda
- WADA
- Unclear
- Not named on the 2026 list
Current status
Not FDA approved · approved abroadNo. Thymosin Alpha-1 is not FDA approved for any use.
| Country | Status | Source |
|---|---|---|
| United States | No approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "Thymosin Alpha-1" returned no matches on 2 Oct 2026. | api.fda.govchecked 2 Oct 2026 |
Timeline
Compounding and research-use sellers
- Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
- The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
- "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
FDA compounding record: Thymosin alpha-1 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators. · fda.gov, checked 2 Oct 2026
Sport and drug testing
WADA status unclearThe list names thymosin-beta-4 derivatives (S2.3), not thymosin alpha-1, which is a different peptide approved in some countries. S2.3 also covers other growth factor modulators, so we cannot say it is clearly outside the list.
Outside the US
Rules differ by country. What each regulator's own records show, with the date we checked:
| Country | Status | Source |
|---|---|---|
| United Kingdom | No approved product foundNo approved product found in an emc (UK SmPC compendium) search for "Thymosin Alpha-1" on 2 Oct 2026. | medicines.org.ukchecked 2 Oct 2026 |
| Canada | No approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "Thymosin Alpha-1" on 2 Oct 2026. | health-products.canada.cachecked 2 Oct 2026 |
| Australia | No approved product foundNo approved product found in an ARTG search for "thymalfasin" on 2 Oct 2026. | tga.gov.auchecked 2 Oct 2026 |
| European Union | No centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026 | ema.europa.euchecked 2 Oct 2026 |
What regulator databases show for thymalfasin
The openFDA Drugs@FDA search for thymalfasin as an active ingredient found no application.[2]
Health Canada's drug product database returned no active-ingredient records for thymalfasin.[5]
The Australian Register of Therapeutic Goods search for thymalfasin had no matching results.[6]
The UK emc search for thymalfasin returned no search results.[4]
What the peptide is, and where studies say it is used
A review describes thymalfasin as a 28-amino acid synthetic polypeptide originally isolated from a bovine thymus extract.[8]
A multicentre cohort study says it is widely used to treat COVID-19 patients in China while its efficacy remains unclear.[9]
Common questions
Is thymosin alpha 1 FDA approved?
The cached Drugs@FDA search for thymalfasin found no application, and a separate FDA safety-risk table is covered on the template.[2]
Is Thymosin Alpha-1 legal to buy?
It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.
Is Thymosin Alpha-1 banned by WADA?
It is unclear. The list names thymosin-beta-4 derivatives (S2.3), not thymosin alpha-1, which is a different peptide approved in some countries. S2.3 also covers other growth factor modulators, so we cannot say it is clearly outside the list.
Is thymosin alpha 1 legal in Canada or Australia?
Health Canada's drug product database and the Australian register searches returned no records for thymalfasin.[5]
More on Thymosin Alpha-1
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "Thymosin Alpha-1" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3US compounding: Thymosin alpha-1 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 4United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "Thymosin Alpha-1" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
- 5Canada: No product found in a Health Canada Drug Product Database search for ingredient "Thymosin Alpha-1" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
- 6Australia: No approved product found in an ARTG search for "thymalfasin" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
- 7EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
- 8Thymalfasin for the treatment of chronic hepatitis B.Expert review of anti-infective therapy · 2004PMID 15482167Accessed 2 Oct 2026
- 9Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.Frontiers in immunology · 2021PMID 34408744Accessed 2 Oct 2026
Found an error? Report a correction.